Pathophysiology of ascites and dilutional hyponatremia: Contemporary use of aquaretic agents
Ascites, the most common complication of cirrhosis, is associated with a poor quality of life, an increased risk of infection, and renal failure. Twenty percent of cirrhotic patients have ascites at the time of diagnosis, while 30% and 50% will develop ascites by 5 and 10 years, respectively. There...
Main Authors: | Jorge García Leiva, Julio Martínez Salgado, Jose Estradas, Aldo Torre, Misael Uribe |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2007-10-01
|
Series: | Annals of Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268119319015 |
Similar Items
-
From Water to Aquaretics: a Legendary Route
by: Valentina Donato, et al.
Published: (2014-05-01) -
Use of tolvaptan in patients hospitalized for worsening chronic heart failure with severe hyponatremia: The initial experience at a single-center in Turkey
by: Saim Sağ, et al.
Published: (2017-07-01) -
Combined aquaretic and diuretic therapy in acute heart failure
by: Goyfman M, et al.
Published: (2017-06-01) -
The aquaretics in the treatment of hyponatremia
by: I. Portioli
Published: (2013-05-01) -
Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia
by: Shuzhen Wang, et al.
Published: (2018-09-01)